Electra Therapeutics
South San Francisco, United States · $267.0M raised
- Headquarters
- South San Francisco, California
- Business Model
- B2B
- Website
- electra-therapeutics.com
- Total Funding
- $267.0M
- Last Round
- $183.0M Series COct 2025
- Rounds
- 2
About
Clinical-stage biotech developing SIRP-targeting therapies for autoimmune diseases and cancer with unmet medical needs.
Summary
Electra Therapeutics is a Biotech company based in South San Francisco, United States. It has raised $267.0M in total across 2 rounds, most recently a $183.0M Series C round in Oct 2025. Investors include EQT Life Sciences, Nextech and Westlake Village BioPartners.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...